Opinion
Video
Author(s):
Josie Montegaard, MSN, AGPCNP-BC, offers expert perspectives on treatment considerations in CLL, focusing on BTK inhibitors and venetoclax-based therapy.
Brukinsa Shows Favorable Safety Profile Over Imbruvica in CLL
A Chance of Cure for Cervical Cancer, Lymphedema Treatment Act and More
Why Hope is Important For Patients with Chronic Lymphocytic Leukemia
The Treatment Journey of a Patient with CLL
Waiting for Results After My CLL Diagnosis
Learning to ‘Let it Be’ After Poor Test Results